ZS PHARMA, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 71
- Market Cap
- -
- Website
- http://zspharma.com
POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study
- First Posted Date
- 2015-11-20
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 240
- Registration Number
- NCT02609841
REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study
Completed
- Conditions
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2017-06-08
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 203
- Registration Number
- NCT02607085
Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months
- First Posted Date
- 2014-06-13
- Last Posted Date
- 2018-06-27
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 751
- Registration Number
- NCT02163499
Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2018-08-15
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 123
- Registration Number
- NCT02107092
Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-03-14
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 258
- Registration Number
- NCT02088073
Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2014-09-03
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT01866709
- Locations
- 🇺🇸
Riverside Clinical Research, Edgewater, Florida, United States
Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 754
- Registration Number
- NCT01737697
- Locations
- 🇺🇸
Carolina Diabetes and Kidney Center, Sumter, South Carolina, United States
🇺🇸Nephrology and Hypertension Associates, Middlebury, Connecticut, United States
🇺🇸South Carolina Nephrology & Hypertension, Orangeburg, South Carolina, United States
Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-12-15
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT01493024
- Locations
- 🇺🇸
West Coast Clinical Trials, Costa Mesa, California, United States
🇺🇸Southwest Houston Research, Ltd, Houston, Texas, United States
🇺🇸Renal Associates, P.A., San Antonio, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath